72
Views
18
CrossRef citations to date
0
Altmetric
Original

Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 129-135 | Received 07 Sep 2005, Accepted 01 Feb 2006, Published online: 07 Jul 2009

References

  • Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570–1580
  • Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis 2002; 22(3)291–302
  • Shimoda S, Nakanuma M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: Evidence of molecular mimicry in human autoimmune disease. J Exp Med 1995; 181: 1835–1845
  • Fussey SP, Ali ST, Guest JR, James OF, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis with Escherichia coli dihydrolipoamide acetyltransferase (E2p): Characterization of the main immunogenic region. Proc Natl Acad Sci 1990; 87(10)3987–3991
  • Sheagren JN. Staphylococcus aureus. The persistent pathogen. N Engl J Med 1984; 310: 1437–1442
  • Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J, et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 2004; 66(1)121–132
  • Visser L, Jan de Heer H, Boven LA, van Riel D, van Meurs M, Melief MJ, et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 2005; 174(2)808–816
  • Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003; 133(3)299–306
  • Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, et al. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 2000; 33(1)9–18
  • Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: Is propionibacterium acnes involved in granuloma formation?. Hepatology 2001; 33: 530–536
  • Fischer W. Physiology of lipoteichoic acid in bacteria. Adv Microb Physiol 1988; 29: 233–302
  • Ohshima Y, Ko HL, Beuth J, Roszkowski W, Roszkowski W. Biological properties of staphylococcal lipoteichoic acid and related macromolecules. Zentralbl Bakteriol 1990; 274: 359–365
  • Keller R, Fischer W, Keist R, Basseti S. Macrophage response to bacteria: Induction of marked secretory and cellular activity by lipoteichoic acids. Infect Immun 1992; 60: 3664–3672
  • Shibata M, Onozuka Y, Morizane T, Koizumi H, Kawaguchi N, Miyakawa H, et al. Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. J Gastroenterol 2004; 39: 255–259
  • Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967; 60: 1257–1260
  • Toda G, Oonishi S. Diagnostic criteria for primary biliary cirrhosis (in Japanese). Acta Hepatol Jpn 2005; 46: 232–233
  • Hughes R. Campylobacter jejuni in Guillain–Barre syndrome. Lancet Neurol 2004; 3(11)644
  • Tsang RS. The relationship of Campylobacter jejuni infection and the development of Guillain–Barre syndrome. Curr Opin Infect Dis 2002; 15(3)221–228
  • Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: An update. Helicobacter 2004; 9(4)342–346
  • Oldstone MBA. Molecular mimicry and immune-mediated disease. FASEB J 1998; 12: 1255–1265
  • Jones DEJ, Palmer JM, Burt AD, Walker C, Robe AJ, Kirby JA. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 2002; 36: 679–686
  • Yeaman SJ, Kirby JA, Jones DE. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000; 174: 238–281
  • Tsuneyama K, Harada K, Kono N, Hiramatsu K, Zen Y, Sudo Y, et al. Scavenger cells with Gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J Hepathol 2001; 35: 156–163
  • Palmer JM, Doshi M, Kirby JA, Yeaman SJ, Bassendine MF, Jones DE. Secretory autoantibodies in primary biliary cirrhosis (PBC). Clin Exp Immunol 2000; 122: 423–428
  • Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: An orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210–225
  • Masuda J, Omagari K, Ohba K, Hazama H, Kadokawa Y, Kinoshita H, et al. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis. Dig Dis Sci 2003; 48(5)932–938
  • Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003; 3: 822–829
  • Haruta I, Hashimoto E, Kato Y, Miyakawa H, Shibata N, Kobayashi M, et al. Intrahepatic biliary epithelial cell damage and inflammation in portal tract in association with chronic colitis-harboring TCRα− / − mice. Hepatol Res 2006; 34: 3–8
  • Sakashita S, Kawaguchi T, Taniguchi E, Hanada S, Sasatomi K, Koga H, et al. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2001; 33: 1460–1468
  • Jones DF, Palmer JM, Burt AD, Walker C, Robe AJ, Kirby JA. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 2002; 36: 679–686

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.